About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Viral Triggers in Pediatric Lung Transplantation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00891865

Viral Triggers in Pediatric Lung Transplantation

The purpose of this study is to determine whether respiratory viral infections increase the risk of bronchiolitis obliterans syndrome (BOS), obliterative bronchiolitis (OB), death, or retransplantatio...

Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID)•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Age

0 - 21 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Parent or legal guardian willing and able to provide informed consent
•Participant of first single or bilateral heart-lung transplant

Exclusion Criteria

•Recipient of multi-organ transplant (aside from heart-lung)
•Condition or characteristic which in the opinion of the investigator makes the participant unlikely to complete the study

Related studies

RECRUITINGPhase 2

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

NCT06476132 · Lung Transplant

RECRUITINGPhase 2

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

NCT07046910 · Lung Transplant Rejection

Trifecta-Lung cfDNA-MMDx Study

NCT05837663 · Lung Transplantation

RECRUITINGPhase 4

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

NCT07235683 · CMV, Lung Transplant Recipient

Thoracic Specimen Registry

NCT04118660 · Thoracic Diseases, Lung Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 2, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment61

Start dateJun 2009

Last updatedJul 2, 2020

Condition

Lung Transplant Bronchiolitis Obliterans Obliterative Bronchiolitis

Locations shown

Stanford University

Palo Alto, California

Children's Hospital Boston

Boston, Massachusetts

Washington University

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 2, 2020Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions